-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse Tradegate System der Deutsche Börse AG (60%)Symbol 6L9-
ViewRayBörse Börse FrankfurtSymbol 6L9
-
VIEWRAY INCBörse Börse StuttgartSymbol 6L9
-
VIEWRAY INCBörse Tradegate System der Deutsche Börse AG (60%)Symbol 6L9
-
VIEWRAY INCBörse Gettex System der Börse MünchenSymbol 6L9
-
VIEWRAY INCBörse Börse BerlinSymbol 6L9
-
ISIN US92672L1070 WKN: A2AE2SSymbol VRAY
-
ISIN US92672L1070 WKN: A2AE2SSymbol VRAY
-
Symbol 6L9
-
EUR
-
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
816.212.096 oder 915.000.000
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
309 oder 295 Mitarbeiter
6 ETFs die in ViewRay investieren
Dir gefallen die Informationen zu ViewRay?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu ViewRay?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu ViewRay?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu ViewRay?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
30 News & Informationen zur ViewRay Aktie
ViewRay CFO makes insider purchase of over $200K worth of shares (NASDAQ:VRAY)
ViewRay (VRAY) has added ~6.2% in the pre-market on below average volume after the company disclosed on Wednesday that its chief financial officer Stassen Zachary William purchased…
Viewray Inc (VRAY) CFO Zachary William Stassen Bought $212,800 of Shares
GuruFocus Article or News written by insider and the topic is about:
ViewRay : Amsterdam University Medical Centers establishes same-day ablative treatment service using MRIdian® to Streamline the Patient Experience.
CLEVELAND, Aug. 24, 2021 /PRNewswire/ — ViewRay, Inc. today announced that the clinical team at Amsterdam University Medical Centers has started offering same-day ablative treatment using… | August 24, 2021
Amsterdam University Medical Centers establishes same-day ablative treatment service using MRIdian® to Streamline the Patient Experience.
/PRNewswire/ — ViewRay, Inc. (NASDAQ: VRAY) today announced that the clinical team at Amsterdam University Medical Centers (Amsterdam UMC) has started…
Amsterdam University Medical Centers Establishes Same-day Ablative Treatment Service Using MRIdian® To Streamline The Patient Experience.
CLEVELAND, Aug. 24, 2021 /PRNewswire/ — ViewRay, Inc. VRAY today announced that the clinical team at Amsterdam University Medical Centers (Amsterdam UMC) has
Pura Vida Investments, Llc Buys ATAI Life Sciences NV, Apria Inc, Agilon Health Inc, Sells , Vericel Corp, Align Technology Inc
GuruFocus Article or News written by insider and the topic is about:
ViewRay : UCLA Health Treats its 1,000th Patient Using MRIdian® MRI-Guided Radiation Therapy
CLEVELAND, Aug. 17, 2021 /PRNewswire/ — ViewRay, Inc. today announced that UCLA Health joins the Siteman Cancer Center at Washington University, Seoul National University Hospital and Amsterdam… | August 17, 2021
UCLA Health Treats its 1,000th Patient Using MRIdian® MRI-Guided Radiation Therapy
/PRNewswire/ — ViewRay, Inc. (NASDAQ: VRAY) today announced that UCLA Health joins the Siteman Cancer Center at Washington University, Seoul National…
ViewRay, Inc. (VRAY) CEO Scott Drake on Q2 2021 Results – Earnings Call Transcript
ViewRay, Inc. (NASDAQ:VRAY) Q2 2021 Earnings Conference Call August 5, 2021 04:30 PM ET Company Participants Ashley Kluth – Head of Investor Relations Scott Drake – President & Chief…
Why ViewRay Stock Is Sinking Today
Investors didn't like the company's Q2 update.
ViewRay, Inc. 2021 Q2 – Results – Earnings Call Presentation (NASDAQ:VRAY)
The following slide deck was published by ViewRay, Inc.
Were Hedge Funds Right About Betting On ViewRay, Inc. (VRAY)?
Is ViewRay, Inc. (NASDAQ:VRAY) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by…
ViewRay : Miami Cancer Institute Enrolls First Patients in Single-Fraction Stereotactic MRI-Guided Adaptive Radiation Therapy for Inoperable Primary or Metastatic Cancer Trial
CLEVELAND, July 7, 2021 /PRNewswire/ — ViewRay, Inc. today announced that the Miami Cancer Institute, part of Baptist Health South Florida, has enrolled the first patients in its Stereotactic… | July 7, 2021
Surna Cultivation Technologies Announces R. Brian Knaley As New CFO
Senior Finance Executive & CPA , NYSE & Nasdaq Company Veteran to Lead Capital Markets and Finance Strategy
Boulder, Colorado, June 29, 2021 (GLOBE
ViewRay price target more than doubled at Morgan Stanley on GenesisCare deal (NASDAQ:VRAY)
Yesterday, ViewRay <> announced that GenesisCare, the largest provider of cancer services globally, has entered into a purchase agreement with the company for up to…
ViewRay (VRAY) Stock Jumps 11.7%: Will It Continue to Soar?
ViewRay (VRAY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Why ViewRay Crushed the Market on Thursday
The company announced an exciting new deal with a major specialist company from Down Under.
GenesisCare Expands their MR-guided Radiotherapy Reach with the Purchase of Multiple MRIdian® Systems
Master agreement includes program plans for up to a further 14 systems with immediate expansion in 2 key marketsCLEVELAND, June 24, 2021 /PRNewswi…
ViewRay : GenesisCare Expands their MR-guided Radiotherapy Reach with the Purchase of Multiple MRIdian® Systems
Master agreement includes program plans for up to a further 14 systems with immediate expansion in 2 key markets
CLEVELAND, June 24, 2021 /PRNewswire/ — ViewRay, Inc. today announced that… | June 24, 2021
Cancer Patients Across the U.S. to Benefit from GenesisCare's Partnership with ViewRay, Inc.
/PRNewswire/ — GenesisCare—one of the leading oncology providers in the United States, Australia, Spain, and the United Kingdom—today announced it expanded…
ALDX Catches Eye, RVNC Faces Busy Year Ahead, SRPT Plunges On DMD Trial Data
Today's Daily Dose brings you news about Alnylam's transthyretin-mediated (ATTR) amyloidosis trial results; Sarepta's mixed results of investigational gene therapy SRP-9001 in patients with Duchenne muscular dystrophy; Aldeyra's dry eye disease trial results; and Revance's anticipated milestones.
Pre-market Movers In Healthcare Sector: CHEK, SYN, NSPR, ZOM, BNGO, VRAY…
What’s moving these stocks in pre-market hours today?.
CALA Falls As CANTATA Trial Fails, Haven Healthcare To Be Disbanded, MTNB Awaits MAT9001 Data In Q1
Today’s Daily Dose brings you news about Pandion’s phase Ia trial of autoimmune disease drug PT101 in healthy volunteers; Matinas BioPharma’s anticipated milestone for this quarter; Calithera’s disappointing results from phase II study of Telaglenastat in patients with renal cell carcinoma, Provention Bio’s near-term regulatory catalyst; and disbanding of Haven Healthcare joint venture.
CALA Falls As CANTATA Trial Fails, Haven Healthcare To Be Disbanded, MTNB Awaits MAT9001 Data In Q1
(RTTNews) – Today’s Daily Dose brings you news about Pandion’s phase Ia trial of autoimmune disease drug PT101 in healthy volunteers; Matinas BioP…
ViewRay Announces Pricing of Public Offering of Common Stock
/PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat…
ViewRay Announces Proposed Public Offering of Common Stock
/PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat…
Magellan Health, FLIR Systems: 5 Top Stock Gainers for Monday
Magellan Health, FLIR Systems, Brookfield Property Partners, ViewRay and Pandion Therapeutics are five top stock gainers for Monday.
Stocks That Hit 52-Week Highs On Monday
During Monday’s morning session, 286 stocks hit new 52-week highs.
Areas of Interest: The company with the largest market cap to set a new …
Why Is It Moving? Looking At ViewRay’s Price Action Today
The Price And Volume Action In ViewRay’s Stock Today
ViewRay’s (NASDAQ: VRAY) stock has been rising Monday, up 26.3% to a price of $5.03. The …
ViewRay Announces Preliminary Fourth Quarter and Full Year 2020 Results
CLEVELAND, Ohio, Jan. 4, 2021 /PRNewswire/ — ViewRay, Inc. (NASDAQ:VRAY) today announced preliminary results for the fourth quarter and full fiscal year …